[ORGANIZATION]
Galleri
Featured in 3 tracked stories · first seen
Situations
FDA panel recommends benefits of Grail Galleri test
2 clusters · 20 sources · last updated
Latest: FDA panel recommends benefits of Grail's Galleri cancer blood test outweigh risks
GRAIL, Inc. is undergoing a regulatory review by an FDA advisory panel regarding its Galleri multi-cancer early detection blood test. The test, intended for adults aged 50 and older, identifies DNA fragments shed by tumo
FDA review of Grail Galleri cancer blood test
2 clusters · 2 sources · last updated
Latest: Biotech firms Grail and CRISPR Therapeutics see regulatory developments
The U.S. Food and Drug Administration (FDA) has scheduled an advisory committee meeting for September 23, 2026, to review the premarket approval application for Grail Inc.’s Galleri multi-cancer early detection (MCED) bl